SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?


To: Bid Buster who wrote (314071)10/27/2005 10:10:54 AM
From: MythMan  Read Replies (3) | Respond to of 436258
 
nah, just joking around. Looks like we'll hold up above 10K.

edit...what whacked JNJ?

second edit...

>>Standard & Poor's Equity Research analyst Robert Gold reiterated a "buy" rating on Johnson & Johnson (nyse: JNJ - news - people ) after the company received a nonapprovable letter from the Food and Drug Administration on Dapoxetine, a compound for treatment of premature ejaculation.<<

LOL